Press Releases
Press Releases
| Date | Press Releases | Topic |
|---|---|---|
| Apr 2, 2013 |
An examination of a Salmonella Heidelberg outbreak linked to ground turkey illustrates that health authorities must be more aggressive in their efforts to detect and respond to foodborne illnesses, according to a new report by The Pew Charitable Trusts, titled “Too Slow: An Analysis of the 2011 Salmonella Ground Turkey Outbreak and Recommendations for Improving Detection and Response.” In all, the contaminated food sickened a reported 136 people in the United States, hospitalized 37 and killed one, according to government data. |
Food Safety |
| Mar 20, 2013 |
Pew Commends Senators Gillibrand and Feinstein for Working to Shine Light on Antibiotics Practices The Senate Health, Education, Labor and Pensions Committee today adopted the Animal Drug User Fee Act, which failed to include provisions from Senators Kirsten Gillibrand (D-NY) and Dianne Feinstein (D-CA) that would improve the Food and Drug Administration's annual reporting of antibiotic sales for use on industrial farms. |
Antibiotics in Food Animal Production |
| Mar 5, 2013 |
Funding Available in Minnesota to Identify Health Opportunities, Risks of Upcoming Decisions The Health Impact Project announces a request for proposals (RFP) that will fund three grants of up to $100,000 each to identify and address potential health impacts of an upcoming decision in each of their communities or state through the use of health impact assessments (HIA). |
Health Impact Assessment |
| Feb 26, 2013 |
Pew Applauds New Antibiotics Legislation The Pew Charitable Trusts today applauded Rep. Henry Waxman (D-Calif.) and Rep. Louise Slaughter (D-N.Y.) for introducing the Delivering Antimicrobial Transparency in Animals (DATA) Act (H.R. 820) in the U.S. House of Representatives. The bill would authorize the U.S. Food and Drug Administration (FDA) to collect and report data that would shed light on how antibiotics are being used on industrial farms. |
|
| Feb 1, 2013 |
Pew Commends Strong Transparency Rule for Physician-Industry Relationships Allan Coukell, director of medical programs for The Pew Charitable Trusts, issued the following statement in response to the Centers for Medicare & Medicaid Services' final rule for implementing the Physician Payments Sunshine Act, which will bring transparency to the financial relationships between physicians and drug and medical device companies. |
Conflicts of Interest |
| Jan 23, 2013 |
Training Available In Minnesota To Build Healthier Communities Through Health Impact Assessment Minnesota organizations are invited to participate in an in-person training to learn about health impact assessments (HIAs). An HIA can help improve the well-being of local communities by incorporating health into decisions in other sectors. |
Health Impact Assessment |
| Jan 4, 2013 |
Pew Thanks President Obama for Fulfilling Promise to Make Our Food Safe Erik Olson, director of food programs at The Pew Charitable Trusts, issues the following statement on Jan. 4, 2013 release of major draft regulations to implement the FDA Food Safety Modernization Act (FSMA), which President Barack Obama signed two years prior on Jan. 4, 2011. |
Food Safety |
| Nov 12, 2012 |
America Gets Mixed Score on ''Antibiotics IQ'' Test Nearly nine in 10 Americans recognize that antibiotics are effective treatments for fighting bacterial infections like strep throat, but more than a third mistakenly believe the drugs are also appropriate treatments for viral infections such as the common cold. |
Antibiotic Innovation |
| Nov 1, 2012 |
When It Comes to Healthy Snacks, Many Schools Do Not Make the Grade A new report finds that in all but one state, fewer than half of secondary schools sold fruit or vegetables as snacks in 2010. |
School Food |
| Oct 15, 2012 |
Pew Comments on Proposed Antibiotics Legislation Laura Rogers, project director for the Pew Campaign on Human Health and Industrial Farming, issued a statement in support of legislation proposed by Rep. Henry Waxman’s (D-CA) that would enable the FDA and the public to verify whether the agency's efforts toward providing guidance on limiting the overuse and misuse of antibiotics are actually working. |
